openPR Logo
Press release

Global HPV Vaccine Market Analysis and Forecast, 2019-2028 - In-depth Market Report by RationalStat

10-21-2022 08:48 AM CET | Health & Medicine

Press release from: RationalStat LLC

Global HPV Vaccine Market Analysis and Forecast, 2019-2028

Global HPV Vaccine Market Analysis and Forecast, 2019-2028

The report titled "Global HPV Vaccine Market" assesses the global market based on type, indication, distribution channel, and region. A comprehensive report provides a detailed historical and future market size with trend analysis. The market share analysis, production capabilities of the top companies, an overview of the competition, strategic imperatives, potential growth areas, and competition analysis for the target players evaluated in the global HPV vaccine market study are highlighted in the report.

Market Overview and Dynamics: Growing prevalence of HPV-associated diseases fuels the demand for HPV vaccines

The global HPV vaccine market is expected to grow at a CAGR of around 7% during the forecast period of 2022-2028. The initiatives taken by governments across the globe are expected to increase the demand for HPV vaccines as they focus on eradicating the disease. Moreover, stringent government regulations are expected to further fuel the demand for HPV vaccines in the forthcoming years.
Furthermore, the growing support by the manufacturers to back governmental organizations and meet the demands is anticipated to upsurge the demand for the same. In addition, the government initiatives and steps taken by global health organizations like "GAVI" are expected to create a pool of opportunities for HPV vaccines in the upcoming years.
Additionally, public demand for the HPV vaccine may be influenced by the level of knowledge, awareness, and attitude of various stakeholders involved in the HPV vaccination program. According to WHO, In Europe, more than 66,000 women are diagnosed with cervical cancer and more than 30,000 of them die annually from cervical.

Segmental Analysis

• Based on type, the 9-Valent Vaccine (Gardasil 9) segment is expected to dominate the global HPV vaccine market owing to the significant demand for the 9-valent vaccine as it protects from nine HPV types (6, 11, 16, 18, 31, 33, 45, 52, and 58) and helps in reducing the further incidence of HPV related cancer.
• Based on Indication, Cervical cancer is expected to dominate the sales of HPV vaccines as the demand for HPV vaccines is increasing as immunization against cervical cancer is gaining traction.
• Based on the Distribution Channel, Doctor offices/ Hospitals, and Retail pharmacies are anticipated to hold a dominant share in the market as hospitals are well equipped with all necessary equipment needed for treatment and other related purposes.

Competition Analysis: Regional Players Dominate the Domestic Markets

Due to the presence of many well-established companies in the global HPV vaccine sector, there is intense competition. In order to preserve a competitive advantage in the market, the government has boosted its investment in HPV vaccines and is focusing on the complete eradication of HPV-associated cancers.
Acquisitions, product launches, and partnerships are the identified industry trend in the global HPV vaccine market. Significant consolidation is expected in the global market during the assessed period 2022-2028.
• In September 2022, India's indigenously developed cervical cancer vaccine (qHPV Vaccine) with the partnership between the Serum Institute of India (SII), the Department of Biotechnology (DBT), and the Biotechnology Industry Research Assistance Council (BIRAC).
• In April 2022, Merck & Co. announced the expansion of its vaccine manufacturing in Virginia to 120,000 square ft. to increase the capacity and supply of the HPV vaccine.

Some of the prominent players operating in the global HPV vaccine market include Merck & Co., GlaxoSmithKline plc, Serum Institute of India Pvt. Ltd., Johnson & Johnson, AstraZeneca, Walvax Biotechnologies, Innovio Pharmaceuticals, Chengdu Institute of Biological Products Co., Ltd., Sanofi, and Shanghai Bowei among others.
Among these, Merck & Co. and GlaxoSmithKline plc are the prominent manufacturers and suppliers of the HPV vaccine.
RationalStat has segmented the global HPV vaccine market on the basis of type, indication, distribution channel, and region
• By Type
o 9-Valent Vaccine
o Quadrivalent Vaccine
o Bivalent Vaccine
• By Indication
o Cervical Cancer
o Genital Warts
o Oropharyngeal Cancer
o Vulvar Cancer
o Vaginal Cancer
o Anal Cancer
o Others (Head Cancer, Neck Cancer, etc.)
• By Distribution Channel
o Doctor Offices / Hospitals
o School-Based Health Centers
o Government Suppliers
o Retail Pharmacies
o Online Pharmacies
• By Region
o North America
o Latin America
o Western Europe
o Eastern Europe
o Asia Pacific
o Middle East & Africa

For more information about this report https://store.rationalstat.com/store/global-hpv-vaccine-market/

RationalStat LLC
Kimberly Shaw, Content and Press Manager
sales@rationalstat.com
Phone: +1 302 803 5429

RationalStat is an end-to-end US-based market intelligence and consulting company that provides comprehensive market research reports along with customized strategy and consulting studies. The company has sales offices in India, Mexico, and the US to support the middle east and diversified businesses. The company has over 80 consultants and industry experts, developing more than 850 market research and industry reports for its report store annually.
RationalStat has strategic partnerships with leading data analytics and consumer research companies to cater to the client's needs. Additional services offered by the company include consumer research, country reports, risk reports, procurement intelligence, data analytics, and analytical dashboards.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global HPV Vaccine Market Analysis and Forecast, 2019-2028 - In-depth Market Report by RationalStat here

News-ID: 2774894 • Views:

More Releases from RationalStat LLC

Latest Market Study | Global Lipstick Filling Machine Market Size, Share, & Forecast 2023-2030
Latest Market Study | Global Lipstick Filling Machine Market Size, Share, & Fore …
The global lipstick filling machine market is expected to reach US$ 88.2 million by 2030, with an annual growth rate of more than 4.5%. According to RationalStat's recent industry analysis, the Global Lipstick Filling Machine Market value is estimated at US$ 64.8 million in 2023 and is expected to rise at a strong CAGR of over 4.5% over the forecast period of 2023-2030. Market Definition, Market Scope, and Report Overview A lipstick
Published Market Report | Global Railway Systems Market Size, Share, & Forecast 2023-2030
Published Market Report | Global Railway Systems Market Size, Share, & Forecast …
The global railway systems market is expected to reach US$ 29.2 billion by 2030, with an annual growth rate of more than 3.6%. According to RationalStat's recent industry analysis, the Global Railway Systems Market value is estimated at US$ 22.8 billion in 2023 and is expected to rise at a strong CAGR of over 3.6% over the forecast period of 2023-2030. Market Definition, Market Scope, and Report Overview Railway systems, also known
Published Market Report | Global Window Blinds Market Size, Share, & Forecast 2023-2030
Published Market Report | Global Window Blinds Market Size, Share, & Forecast 20 …
The global window blinds market is expected to reach US$ 3.7 billion by 2030, with an annual growth rate of more than 3.8%. According to RationalStat's most recent industry analysis, the Global Window Blinds Market value is estimated at US$ 2.9 billion in 2023 and is expected to rise at a strong CAGR of over 3.8% over the forecast period of 2023-2030. Market Definition, Market Scope, and Report Overview Window blinds are
Ointment and Cream Manufacturing Plant Market Report 2023 | Ointment and Cream Manufacturing Plant Market Analysis, Trends, Growth Opportunities, and Forecast, 2023-2030
Ointment and Cream Manufacturing Plant Market Report 2023 | Ointment and Cream M …
The global ointment and cream manufacturing plant market is expected to approach US$ 388.7 million by 2030, with an annual growth rate of more than 5.9% Global Ointment and Cream Manufacturing Plant Market is valued at US$ 260.9 million in 2023 and is expected to grow at a significant CAGR of over 5.9% over the forecast period of 2023-2030, according to the published market report by RationalStat Market Definition, Market

All 5 Releases


More Releases for HPV

Rising Prevalence Of HPV-Related Diseases Sparks Surge In Human Papillomavirus ( …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Human Papillomavirus (HPV) Vaccine Market Size Valuation Forecast: What Will the Market Be Worth by 2025? In recent times, there's been speedy growth in the market size for the human papillomavirus (HPV) vaccine. Its worth is forecasted to increase from $5.8 billion in 2024 to $6.63 billion in 2025
Global Human Papillomavirus (HPV) Vaccine Market Report 2025: Insights, Drivers …
The Global Human Papillomavirus (HPV) Vaccine Market size reached US$ 3,043.19 Million in 2024 and is expected to reach US$ 12,361.15 Million by 2033, growing at a CAGR of 16.9% during the forecast period 2025-2033. The Human Papillomavirus (HPV) Vaccines Market Report by DataM Intelligence offers comprehensive insights into the latest market trends, key growth drivers, and emerging challenges. Crafted to support smarter and faster decision-making, our reports blend in-depth data
Rising Prevalence Of HPV-Related Diseases Sparks Surge In Human Papillomavirus ( …
The Human Papillomavirus (HPV) Vaccine Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Expected Human Papillomavirus (HPV) Vaccine Market Size During the Forecast Period? The market size for the human papillomavirus (HPV) vaccine has seen swift growth in the past few years. The
HPV Vaccines Market 2020-2026 - COVID19 Impact On HPV Vaccines Industry | Top Ke …
HPV Vaccines Market Size, Share & Industry Analysis, By Type (Bivalent and Polyvalent), By Disease Indication (HPV Associated Cancer and Genital Warts), By Distribution Channel (Hospital & Retail Pharmacies, Government Suppliers, and Others) and Geography Forecast, 2019-2026. Get Sample Copy Of Report To Know The Impact of Covid19 on this Industry: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/human-papillomavirus-hpv-vaccines-market-101962 Top Key Players: GSK, Merck. An Overview of the Impact of COVID-19 on HPV Vaccines Market: The emergence of COVID-19 has brought
HPV Testing & PAP Test Market by Test Type (HPV Testing, Follow-up HPV Testing, …
Global HPV Testing & PAP Test Market was valued at USD XX billion in the year 2017. Global HPV Testing & PAP Test market is further estimated to grow at a CAGR of XX % from 2018 to reach USD XX billion by the year 2023. Get Free Access to Sample Report @ https://genesismarketinsights.com/Sample_Request/GENRE385 In the Global HPV Testing & PAP Test Market, by region, North America holds the highest market share
Cytology and HPV Testing Market: Disparate Levels of Awareness among Patients Re …
Over the years, the level of awareness among the global population regarding the various types of cancer has increased tremendously. The significance of early detection and diagnosis is not lost on them, resulting in the increased adoption of screening tests such as cytology and human papillomavirus (HPV) testing. The global market for cytology and HPV testing is presented with a host of sustained growth opportunities arising mainly from several emerging economies,